Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 35 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PENIJULLINE from Zonnebeke, company number BE0692832297, closed financial year 2025 with a result of € 585,567 after tax. For that financial year PENIJULLINE recorded a gross margin of € 788,425 and equity of € 18,550. Compared with financial year 2024, the result moved from € 619,352 to € 585,567. The company is profitable. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.
€ 18,550
▼ 98% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 585,567
▼ 5% vs 2024
Profit after tax over the fiscal year.
€ 66,164
▲ 71% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 1.3 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 88,323
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 741
▲ € 560 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 21,000
▲ 67% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 627,665 | € 682,299 | € 732,138 | € 788,425 | ▲ 8% |
| Profit after taxes | € 446,268 | € 519,334 | € 619,352 | € 585,567 | ▼ 5% |
| Equity | € 1,083,029 | € 1,083,029 | € 768,473 | € 18,550 | ▼ 98% |
| Total debts | € 690,477 | € 596,979 | € 475,309 | € 1,194,768 | ▲ 151% |
| Cash | € 1,267,548 | € 995,343 | € 38,752 | € 66,164 | ▲ 71% |
| Retained profit | € 1,064,479 | € 1,064,479 | € 749,923 | € 0 | ▼ 100% |
| Dividend | € 446,268 | € 519,334 | € 933,908 | € 1,335,490 | ▲ 43% |
| Balance sheet total | € 1,773,506 | € 1,680,008 | € 1,243,782 | € 1,213,318 | ▼ 2% |
Key figures of PENIJULLINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PENIJULLINE?
What happened at PENIJULLINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 585,567 (▼ 5% vs 2024). Source: NBB ↗
- New establishment in Zonnebeke. KBO
- Start of the company according to the CBE. KBO
In short
From € 446,268 profit in 2022 to € 585,567 profit in 2025.
Paid € 685,060 in corporate taxes since 2022.
Best year ever: 2024, with € 619,352 profit.
Paid out € 3.2 million in dividends to the owners in total.
Management
Behind PENIJULLINE is Francis DUYCK. It owns 25% of Hashimoto BV itself.
Establishments
Establishment units
Physical locations of this company
Oude Kortrijkstraat 30
8980 Zonnebeke
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0692.832.297
- VAT number
- BE 0692.832.297
- Registered office
- Oude Kortrijkstraat 30, 8980 Zonnebeke
- Names & denominations
- PENIJULLINE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 March 2018
- Peppol
- Active · Active since 17 Jul 2026
- Activities · NACE
Activiteiten van medisch specialisten
Overige zakelijke dienstverlening, neg